ÂÜÀòÂÒÂ×

Lars Grundemar currently serves as the Deputy Chief Executive Officer and Chief Medical Officer at AGB-Pharma AB while also holding the position of Director of the Board at Lead Biologics and AGB Development AB. Additionally, Lars organizes the Lund Spring Symposium and is an Adjunct Professor at Lund University. Lars has been the Managing Director of In Manu Medici LG AB since 1993 and has held various leadership roles, including CEO and Chief Scientific Officer at Oncorena AB and Chairman of the Board at Sinntaxis. Education includes studies at Lund University and Cornell University, as well as being a registered specialist in Clinical Pharmacology.